In the tranquil embrace of nature, amidst whispering trees and fertile soil, Gregory Robinson, CEO and founder of Mycos and Mycos Biotech, discovered his passion for the extraordinary realm of mushrooms. Guided by his fascination, he embarked on a journey of exploration under the supervision of Dr. Igor Kovalchuk in the Department of Biological Sciences.
"The marvels of mushrooms have always intrigued me," Gregory reflects. "In the past decade, we've witnessed a remarkable surge in mushroom-based research, particularly with the newfound recognition of psychedelics' therapeutic value. This ignited my fascination and propelled me on a quest for exploration."
Armed with his expertise in mycology and an ongoing pursuit of a Ph.D. at the University of Lethbridge, Gregory delved into the mysteries of mushrooms. With funding from Mitacs Accelerate Entrepreneur and the University's Incubator, Agility, he embarked on a mission to bridge critical gaps in the research landscape.
"We identified a critical gap in the research landscape," Gregory explains. "Psychedelic mushrooms, in particular, remained shrouded in mystery despite their potential therapeutic benefits. By delving into cultivation, genomics, and metabolomics, we sought to unlock their hidden treasures."
Their current research project signifies a pivotal moment in fungal exploration. Gregory and his team are pioneering the development of mushroom-based extracts that target diverse ailments, ranging from diabetes and depression to mental health and obesity.
"Our mission is clear: to enhance lives," Gregory asserts. "Whether by extending lifespans, elevating the quality of life, or combating diseases, we endeavour to make a tangible impact using natural, safe products."
Amidst the enthusiasm surrounding psychedelic mushrooms, Gregory emphasizes embracing the broader spectrum of fungal diversity.
"While psychedelic mushrooms command attention for their therapeutic potential, non-psychedelic varieties harbour equally enchanting properties," he notes. "By illuminating their multifaceted benefits, we hope to foster a deeper appreciation for the wonders of mycology."
Beyond the laboratory, Gregory finds solace in sports and exercise, underscoring the significance of balance in both professional and personal pursuits.
As Mycos & Mycos Biotech garners acclaim, including a prestigious win at Alberta's Innovation Rodeo Pitch competition, Gregory envisions a future where their science-backed mushroom extracts reach global communities, catalyzing transformation on a global scale.
With each breakthrough, Gregory and his team illuminate the intricate pathways of psychedelic mushrooms, urging caution amidst the allure of nature's bounty. Their collaborative efforts pave the way for a brighter, healthier future where mushrooms emerge as nature's most extraordinary gift to humanity. To learn more please click here.
Collaborate, Innovate, Elevate: Together We Shine
For partnership inquiries, please connect with us for captivating University research collaborations.